Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.
Enlaza Therapeutics is a biotechnology research company.
Spyglass Pharma provides medicine for ophthalmic diseases.
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.
ImmunOs Therapeutics is a clinical-stage biotechnology company.
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Primmune Therapeutics is a Biotechnology company.
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Janux Therapeutics received $350.0M in a Post-IPO Equity round. Samsara BioCapital's total known invested capital is $12.8B.
Samsara BioCapital's average investment size is $105.2M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include Dewpoint Therapeutics, Enlaza Therapeutics, Spyglass Pharma, Alpheus Medical, Normunity. These companies were founded in 2020 or later.